Stocksigma LogoStocksigma Logo

Glenmark Pharmaceuticals Schedules Physical Institutional Investor Meetings in Asia and Europe

Glenmark Pharmaceuticals announced its upcoming physical analyst and institutional investor meetings via a regulatory filing

Glenmark Pharmaceuticals Schedules Physical Institutional Investor Meetings in Asia and Europe

Glenmark Pharmaceuticals Ltd 路 Intimation 路 10 Nov 2026, 3:00 am

Glenmark Pharmaceuticals Schedules Physical Institutional Investor Meetings in Asia and Europe Glenmark Pharmaceuticals announced its upcoming physical analyst and institutional investor meetings via a regulatory filing. The company is scheduled to host both group and one-on-one meetings in Taiwan and Singapore from 16th Nov'26 to 18th Nov'26. Additionally, a physical group investor meeting is scheduled to take place in Switzerland on 23rd Nov'26. The company confirmed that no unpublished price-sensitive information will be shared during these interactions.

Original exchange filing (PDF)

More announcements from Glenmark Pharmaceuticals Ltd

All Glenmark Pharmaceuticals Ltd announcements